Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment

被引：4
作者：
Giles, Hannah [1 ]
Pratt, Guy [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 192卷 / 03期
关键词：
JAK2; inhibitors; multiple myeloma; myeloma immune; microenvironment; FUNCTION IN-VITRO; CELL-FUNCTION; RUXOLITINIB; TOFACITINIB; EFFICACY; DISEASE;
D O I：
10.1111/bjh.17277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 422
页数：3
相关论文
共 50 条
[21]   Immune checkpoint inhibitors for multiple myeloma immunotherapy [J].
Zhaoyun Liu ;
Xintong Xu ;
Hui Liu ;
Xianghong Zhao ;
Chun Yang ;
Rong Fu .
Experimental Hematology & Oncology, 12
[22]   Immunologic microenvironment and personalized treatment in multiple myeloma [J].
Rossi, Marco ;
Botta, Cirino ;
Correale, Pierpaolo ;
Tassone, Pierfrancesco ;
Tagliaferri, Pierosandro .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 :S83-S93
[23]   Immune checkpoint inhibitors for multiple myeloma immunotherapy [J].
Liu, Zhaoyun ;
Xu, Xintong ;
Liu, Hui ;
Zhao, Xianghong ;
Yang, Chun ;
Fu, Rong .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[24]   Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling [J].
Wang, Jin ;
Hu, Yi ;
Hamidi, Habib ;
Dos Santos, Cedric ;
Zhang, Jingyu ;
Punnoose, Elizabeth ;
Li, Wenjin .
FRONTIERS IN ONCOLOGY, 2022, 12
[25]   TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma [J].
Xue, Han-Yue ;
Wei, Fang .
ANNALS OF HEMATOLOGY, 2024, 103 (11) :4351-4362
[26]   Proteasome inhibitors in the treatment of multiple myeloma [J].
McBride, Ali ;
Ryan, Patricia Y. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (03) :339-358
[27]   Proteasome inhibitors for the treatment of multiple myeloma [J].
Scalzulli, Emilia ;
Grammatico, Sara ;
Vozella, Federico ;
Petrucci, Maria Teresa .
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (04) :375-386
[28]   Proteasome Inhibitors for the Treatment of Multiple Myeloma [J].
Ito, Shigeki .
CANCERS, 2020, 12 (02)
[29]   New JAK2 inhibitors for myeloproliferative neoplasms [J].
Quintas-Cardama, Alfonso ;
Verstovsek, Srdan .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (07) :961-972
[30]   SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma [J].
Zhou, Pan ;
Xiao, Mengyu ;
Li, Weiya ;
Sun, Xiaobai ;
Bai, Yanliang ;
Meng, Feiying ;
Zhu, Zunmin ;
Yuan, Weiping ;
Sun, Kai .
FRONTIERS IN PHARMACOLOGY, 2022, 13
12345